Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2023-11-28 Major Shareholding Noti…
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number' and contains standard regulatory disclosure tables, specifically 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification. The content details the acquisition/disposal of voting rights by IG Markets Limited, crossing a threshold. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2023-11-28 English
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is a 'Half-Year Report' for Cambridge Nutritional Sciences PLC for the period ended 30 September 2023. It contains comprehensive financial statements, including a Consolidated Statement of Comprehensive Income and a Consolidated Balance Sheet, along with management commentary (Chair's Statement). It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2024
2023-11-23 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 3387U' and contains the standard structure for a regulatory notification disseminated via RNS (Regulatory News Service). Specifically, the form title is 'TR-1: Standard form for notification of major holdings', which details changes in share ownership thresholds by a specific person/entity (Spreadex LTD). This type of filing reports changes in significant shareholdings, which corresponds to the Major Shareholding Notification category.
2023-11-22 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled as an 'RNS Number' notification from the London Stock Exchange's news service. The content is a 'TR-1: Standard form for notification of major holdings' concerning an acquisition/disposal of voting rights by Spreadex LTD, crossing a threshold on 17-Nov-2023. This type of filing, which reports changes in significant share ownership, directly corresponds to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-11-20 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and is issued via 'RNS Number : 8720T' by Cambridge Nutritional Sciences PLC. This form is used to report changes in significant share ownership (crossing thresholds) by an entity (Spreadex LTD). This directly corresponds to the definition of a Major Shareholding Notification, which is classified under the code MRQ.
2023-11-17 English
Warrant Expiry and Block Admission Cancellation
Regulatory Filings Classification · 1% confidence The document is clearly identified as an 'RNS Number' announcement from the London Stock Exchange's news service. The content discusses the expiry of warrants and the subsequent cancellation of a Block Admission, which are corporate actions related to capital structure and share issuance. Since this is a formal, brief announcement disseminated via the RNS system, and it deals with a specific corporate action (capital structure change/share issuance mechanics), it fits best under the Capital/Financing Update (CAP) or potentially Share Issue/Capital Change (SHA). However, the core subject is the administrative conclusion of a previous financing event (warrant expiry and block admission cancellation), which is a specific corporate event announcement. Given the structure (RNS Number, date, brief announcement) and the nature of the update (related to capital structure mechanics), 'CAP' (Capital/Financing Update) is a strong fit, as is 'SHA' (Share Issue/Capital Change). Since the document is a direct, short announcement published via RNS, and it details a change related to the company's capital structure (warrants expiring, block admission cancelling), I will classify it as a Capital/Financing Update (CAP) as it relates directly to the mechanics of past financing. The presence of the RNS header strongly suggests it is a regulatory disclosure, but CAP is more specific than the general RNS fallback.
2023-11-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.